Jan 11,2024

Blackford and See-Mode Announce Commercial Partnership

Blackford and See-Mode announced today a commercial partnership to bring See-Mode's Breast & Thyroid Detection solutions to healthcare professionals. See-Mode’s Breast & Thyroid solutions automatically detect and classify lesions found in ultrasound images, reducing reporting time and increasing diagnostic confidence for both ultrasound technologists and radiologists. See-Mode works with images captured using the standard clinical protocols for thyroid and breast ultrasound and supports all major modality manufacturers.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jan 16,2024

Blackford and Bot Image Announce Commercial Partnership

Blackford and Bot Image today announced a commercial partnership to bring Bot Image’s ProstatID solution to healthcare professionals via the Blackford Platform. Under the partnership, Bot Image's innovative technology will be integrated with Blackford's enterprise AI platform. Blackford provides healthcare professionals access to a comprehensive portfolio of more than 115 medical AI solutions designed to drive clinical efficiency and improve patient outcomes. By integrating Bot Image’s advanced technology into the Blackford Platform, Blackford can offer healthcare providers powerful tools for detection of prostate cancer on MR scans.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jan 16,2024

Qure.ai and Project Data Sphere Combine Big Pharma Insights with Deep AI to Drive Cancer Care Forward

Qure.ai and Project Data Sphere, a nonprofit initiative of the CEO Roundtable on Cancer, have announced their partnership to augment tumor assessments using AI-enabled solutions for clinical trials and cancer care. The focus of this collaboration is autoRECIST, a product of Project Data Sphere’s Images and Algorithms program. The program, initiated in consultation with the U.S. Food and Drug Administration, includes stakeholders and experts from across the pharmaceutical industry and academia. In collaboration with Qure.ai, autoRECIST will address the critical need for automating and standardizing tumor response assessments in medical imaging to enhance cancer treatment and research. Rooted in current imaging guidelines, this AI clinical tool will aid radiologists in the detection, selection, measuring and tracking of lesions using defined criteria.

COLLABORATION PARTNERSHIP

#institution

#ai/software

#clinical decision support

View Analyst & Ambassador Comments
Go to original news
Jan 16,2024 TOP STORY

Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening

Lunit announced a three-year supply contract with Samsung Electronics (Samsung Healthcare). The collaboration centers around the integration of Lunit's AI technology into Samsung's premium X-ray devices, elevating the accuracy and speed of chest screening. Under the terms of the contract, Lunit will supply Samsung Electronics with two AI-powered chest screening solutions: Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage. The initial phase of this collaboration will see the X-ray devices, enhanced with Lunit's AI solutions, targeting the markets in the US, Canada, and Europe. Future phases aim to expand this to the Middle East, South America, and Southeast Asia, thereby broadening the global reach.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jan 16,2024

Banner Health reduces generalized anxiety with digital therapeutics

Banner Health, a large nonprofit health system based in Phoenix, faced challenges in behavioral health due to a surge in demand accelerated by the pandemic, a shortage of licensed clinical professionals, and Phoenix experiencing the largest growth in behavioral healthcare needs. To address this, Jeff Johnson, VP of Innovation and Digital Business, proposed using digital therapeutics to provide care for mild and moderate depression and anxiety. For diabetes, Banner aimed to enhance patient and staff efficiencies by addressing the fragmented experience caused by varied data collection methods. They evaluated digital therapeutic products thoroughly, seeking solutions that aligned with both business and clinical needs. The digital therapeutic for behavioral health, SilverCloud, showed positive results, reducing anxiety disorder scores, and Banner is exploring its impact on healthcare utilization and cost containment.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Jan 12,2024

Noom, Liviniti partner on GLP-1 Companion platform

Digital weight loss company Noom announced its commercial business, Noom for Work, is partnering with Liviniti, a national pharmacy benefit manager, to offer plan sponsors and their employees a digital GLP-1 Companion for chronic weight conditions. Noom's GLP-1 Companion integrates with PBM processes, offering nutrition guidance and fitness-focused lessons. Members who sign up for Noom receive a tailored GLP-1 Companion program when they indicate they take a GLP-1 during onboarding. They will also have access to a protein-tracking tool, customized and interactive mini-courses, fitness-focused lessons and videos for people at all activity levels. 

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Jan 08,2024 TOP STORY

Omada Health Joins Amazon’s Health Condition Programs as Launch Partner

Omada Health announced a partnership with Amazon Health Services to increase awareness of its cardiometabolic programs through Amazon’s new Health Condition Programs. Omada will be the first virtual diabetes prevention, diabetes, and hypertension provider available in Amazon’s Health Condition Programs, helping individuals discover and enroll in virtual care benefits that are available to them through their employer or health plan at no extra cost. When Amazon customers browse the site for products that support diabetes prevention, diabetes, and hypertension care, they can now discover an easy way to check their eligibility for health condition programs. Individuals can visit the Amazon Health webpage to initiate a general coverage check. If the check indicates they may be eligible, individuals will then be guided to Omada’s website to complete the enrollment process.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Jan 08,2024 TOP STORY

Omada Health Joins Amazon’s Health Condition Programs as Launch Partner

Omada Health announced a partnership with Amazon Health Services to increase awareness of its cardiometabolic programs through Amazon’s new Health Condition Programs. Omada will be the first virtual diabetes prevention, diabetes, and hypertension provider available in Amazon’s Health Condition Programs, helping individuals discover and enroll in virtual care benefits that are available to them through their employer or health plan at no extra cost. When Amazon customers browse the site for products that support diabetes prevention, diabetes, and hypertension care, they can now discover an easy way to check their eligibility for health condition programs. Individuals can visit the Amazon Health webpage to initiate a general coverage check. If the check indicates they may be eligible, individuals will then be guided to Omada’s website to complete the enrollment process.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Jan 04,2024

Varian and Nova Scotia Health Form First Multi-Disciplinary Oncology Partnership to Catalyze Advancements in Cancer Care

Varian, a Siemens Healthineers company, and Nova Scotia Health have established a 10-year, $175 million CAD multi-disciplinary oncology partnership aimed at advancing cancer care in Nova Scotia. The collaboration seeks to enhance patient outcomes by optimizing the cancer care pathway, from screening to survivorship. The partnership includes upgrading radiation treatment systems to Varian's Ethos radiotherapy systems with HyperSight imaging, incorporating artificial intelligence for improved precision. The collaboration aligns with the shared commitment to revolutionize cancer care and address the evolving needs of clinicians and patients.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 12,2023

Nascentia Health Selects Biofourmis’ Tech-Enabled Care Solution to Boost Aging in Place Programs

Biofourmis announced that it has forged a new agreement with Nascentia Health, which offers a complete range of care management and insurance services that helps patients in Central New York receive the care they need at home. Nascentia Health will leverage Biofourmis’ connected platform to collaboratively grow and launch care-at-home programs aimed at achieving goals such as decreasing adverse outcomes and unnecessary hospital readmissions, reducing average length-of-stay through safe, accelerated transitions to the home, and so forth.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSTITUTION